Who are the key players in Dengue Testing Market?

Thermo Fisher Scientific Inc., InBios International, Inc., NovaTec Immundiagnostica GmbH, F. Hoffmann-La Roche Ltd. and Abbott are the major companies operating in the Dengue Testing Market. Read More

Which is the fastest growing region in Dengue Testing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Dengue Testing Market?

In 2024, the North America accounts for the largest market share in Dengue Testing Market. Read More

What years does this Dengue Testing Market cover, and what was the market size in 2023?

In 2023, the Dengue Testing Market size was estimated at USD 417.13 million. The report covers the Dengue Testing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Dengue Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Dengue Testing Market Size

Market Size of Dengue Testing Industry

Study Period	2019 - 2029
Market Size (2024)	USD 436.19 Million
Market Size (2029)	USD 540.20 Million
CAGR (2024 - 2029)	4.37 %
Fastest Growing Market	Asia Pacific
Largest Market	North America
Market Concentration	High
Major Players *Disclaimer: Major Players sorted in no particular order

Dengue Testing Market Analysis

The Dengue Testing Market size is estimated at USD 436.19 million in 2024, and is expected to reach USD 540.20 million by 2029, at a CAGR of 4.37% during the forecast period (2024-2029).

The Dengue Testing Market is witnessing significant growth due to the increasing global prevalence of dengue fever and the heightened focus on early detection and preventive measures. This market is primarily driven by two major forces: the rising number of dengue cases worldwide and the widespread awareness campaigns designed to educate the public on the risks associated with dengue.

Increasing Incidences of Dengue Cases: Dengue fever has evolved into a global health threat, with nearly half of the world's population now at risk. The rise in dengue cases is linked to various factors, including insufficient funding for effective mosquito control initiatives in many regions. Furthermore, rapid urbanization combined with poor sanitation practices has led to the proliferation of mosquito breeding sites. Climate change has also expanded the habitats of dengue-carrying mosquitoes, resulting in the spread of the disease to new regions, further exacerbating the problem.

Increasing Awareness Campaigns to Educate About the Ills of Dengue: Global governments and healthcare organizations recognize the role of public awareness in the battle against dengue. Public health campaigns are geared towards educating communities on prevention methods, such as the elimination of mosquito breeding grounds. These campaigns also focus on recognizing early symptoms and the importance of prompt medical consultation, encouraging community engagement in the fight against dengue.

Singapore: The National Environment Agency's National Dengue Prevention Campaign educates the public about reducing mosquito habitats.

Philippines: The Department of Health's 2022 campaign in Soccsksargen was launched to counteract rising dengue cases.

India: Delhi's '10 Hafte 10 Baje 10 Minute' campaign highlights preventive measures against dengue.

These campaigns are essential in promoting early testing and driving demand for dengue diagnostic tests, contributing significantly to the market's growth.

The convergence of these factors—rising dengue cases and effective public awareness campaigns—is creating a conducive environment for the expansion of the Dengue Testing Market. As public knowledge of dengue continues to rise and governments enhance their responses, the demand for precise and timely testing solutions will inevitably surge, fostering market growth in the foreseeable future.

Dengue Testing Industry Segmentation

As per the scope of the report, dengue is the most rapidly spreading mosquito-borne viral disease in the world. Blood testing detects viruses or antibodies produced in response to dengue infection. Therefore to control the spread of dengue fever, there are various diagnostic tests to reduce the number of deaths and focus on prevention and cure. The dengue testing market is segmented by product type, end-user, and by geography. By product type, the market is segmented into ELISA-based tests, RT-PCR-based tests, dengue IgG/IgM rapid tests, and other tests. By end-user, the market is segmented into hospitals, diagnostic centers, and other end-users. By geography, the market is segmented into Asia-Pacific and the Americas. The report offers the value (USD) for the above segments.

Product Type
		ELISA-based Tests
		RT-PCR based Tests
		Dengue IgG/IgM Rapid Test
		Other Tests

End User
		Hospitals
		Diagnostic Centers
		Other End Users

Geography

Asia-Pacific
	India
	Philippines
	Indonesia
	Malaysia
	Vietnam
	Thailand
	Sri Lanka
	Rest of Asia-Pacific

Americas
	Brazil
	Mexico
	Nicaragua
	Colombia
	Honduras
	Rest of Americas

Need A Different Region Or Segment?

Customize Now

Dengue Testing Market Size Summary

The dengue testing market is poised for growth, driven by an increasing incidence of dengue cases and heightened awareness campaigns. The COVID-19 pandemic significantly influenced the market, as the overlap in symptoms between dengue and COVID-19 led to a surge in testing. This demand was further fueled by rising dengue cases globally, necessitating urgent public health responses. The market is characterized by the adoption of advanced diagnostic methods, with enzyme-linked immunosorbent assay (ELISA) tests gaining prominence due to their ability to detect dengue virus serotypes and NS1 antigens. Technological advancements in ELISA platforms and the introduction of new diagnostic kits by major players are expected to bolster market expansion.

The Asia-Pacific region is anticipated to be the fastest-growing market, driven by a high prevalence of dengue infections and supportive government initiatives. The region's growth is further supported by the development of innovative diagnostic test kits and strategic partnerships among key industry players. Despite challenges such as the high cost of diagnostic tools, the market is expected to thrive due to the increasing demand for effective testing solutions. The market's consolidation, with significant contributions from companies like Abbott Laboratories and Thermo Fisher Scientific, underscores the competitive landscape and the ongoing efforts to enhance dengue testing capabilities.

Explore More

Dengue Testing Market Size - Table of Contents

1. MARKET DYNAMICS
1. 1.1 Market Overview
2. 1.2 Market Drivers
  1. 1.2.1 Increase Incidences of Dengue Cases
  2. 1.2.2 Increasing Awareness Campaigns to Educate About the Ills of Dengue
3. 1.3 Market Restraints
  1. 1.3.1 Unavailability of Effective Diagnostic Tools
  2. 1.3.2 High Price of Existing Test Kits
4. 1.4 Porter's Five Forces Analysis
  1. 1.4.1 Threat of New Entrants
  2. 1.4.2 Bargaining Power of Buyers/Consumers
  3. 1.4.3 Bargaining Power of Suppliers
  4. 1.4.4 Threat of Substitute Products
  5. 1.4.5 Intensity of Competitive Rivalry
2. MARKET SEGMENTATION (Market Size Value in USD)
1. 2.1 Product Type
  1. 2.1.1 ELISA-based Tests
  2. 2.1.2 RT-PCR based Tests
  3. 2.1.3 Dengue IgG/IgM Rapid Test
  4. 2.1.4 Other Tests
2. 2.2 End User
  1. 2.2.1 Hospitals
  2. 2.2.2 Diagnostic Centers
  3. 2.2.3 Other End Users
3. 2.3 Geography
  1. 2.3.1 Asia-Pacific
    1. 2.3.1.1 India
    2. 2.3.1.2 Philippines
    3. 2.3.1.3 Indonesia
    4. 2.3.1.4 Malaysia
    5. 2.3.1.5 Vietnam
    6. 2.3.1.6 Thailand
    7. 2.3.1.7 Sri Lanka
    8. 2.3.1.8 Rest of Asia-Pacific
  2. 2.3.2 Americas
    1. 2.3.2.1 Brazil
    2. 2.3.2.2 Mexico
    3. 2.3.2.3 Nicaragua
    4. 2.3.2.4 Colombia
    5. 2.3.2.5 Honduras
    6. 2.3.2.6 Rest of Americas